These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 11937780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM, Criscuoli M, Cucchi P, Giachetti A, Gianotti D, Giuliani S, Lecci A, Lippi A, Patacchini R, Quartara L, Renzetti AR, Tramontana M, Arcamone F, Maggi CA.
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [Abstract] [Full Text] [Related]

  • 3. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC, Chapman RW, Richard C, Eckel S, Corboz M, Hey JA, Fernandez X, Greenfeder S, McLeod R, Sehring S, Rizzo C, Crawley Y, Shih NY, Piwinski J, Reichard G, Ting P, Carruthers N, Cuss FM, Billah M, Kreutner W, Egan RW.
    Eur J Pharmacol; 2002 Aug 23; 450(2):191-202. PubMed ID: 12206858
    [Abstract] [Full Text] [Related]

  • 4. Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
    Tramontana M, Patacchini R, Lecci A, Giuliani S, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep 23; 358(3):293-300. PubMed ID: 9774215
    [Abstract] [Full Text] [Related]

  • 5. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):140-8. PubMed ID: 16979621
    [Abstract] [Full Text] [Related]

  • 6. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ, Naeem S, Patel IA, Walpole C, Urbán L.
    Acta Biol Hung; 1996 Nov 07; 47(1-4):129-44. PubMed ID: 9123986
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
    Bellucci F, Carini F, Catalani C, Cucchi P, Lecci A, Meini S, Patacchini R, Quartara L, Ricci R, Tramontana M, Giuliani S, Maggi CA.
    Br J Pharmacol; 2002 Jan 07; 135(1):266-74. PubMed ID: 11786503
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tachykinin receptors mediating contraction of guinea pig lung strips.
    Killingsworth CR, Shore SA.
    Regul Pept; 1995 May 30; 57(2):149-61. PubMed ID: 7544902
    [Abstract] [Full Text] [Related]

  • 13. Endomorphins interact with tachykinin receptors.
    Kosson P, Bonney I, Carr DB, Lipkowski AW.
    Peptides; 2005 Sep 30; 26(9):1667-9. PubMed ID: 16112408
    [Abstract] [Full Text] [Related]

  • 14. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M, Kristensson E, Adolfsson R, Leffler A, Ahlstedt I, Engberg S, Drmota T, Sigfridsson K, Jussila R, de Verdier J, Novén A, Johansson A, Påhlman I, von Mentzer B, Lindström E.
    Eur J Pharmacol; 2007 Dec 22; 577(1-3):78-86. PubMed ID: 17920583
    [Abstract] [Full Text] [Related]

  • 15. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
    Goso C, Astolfi M, Parlani M, Manzini S.
    Eur J Pharmacol; 1995 Dec 27; 294(1):239-45. PubMed ID: 8788437
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
    J Pharmacol Exp Ther; 2001 Jul 27; 298(1):307-15. PubMed ID: 11408556
    [Abstract] [Full Text] [Related]

  • 17. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U, Fehmann H, Bredenbröker D, Klüber D, Lange A, Wichert P.
    Neuropeptides; 1999 Feb 27; 33(1):55-61. PubMed ID: 10657472
    [Abstract] [Full Text] [Related]

  • 18. Spinal effects of selective NK-1 and NK-2 receptor antagonists on bladder motility in anesthetized rats.
    Maggi CA, Lecci A, Garret C, Giuliani S.
    Regul Pept; 1993 Jul 02; 46(1-2):389-91. PubMed ID: 7692545
    [No Abstract] [Full Text] [Related]

  • 19. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
    Maggi CA, Giuliani S, Ballati L, Lecci A, Manzini S, Patacchini R, Renzetti AR, Rovero P, Quartara L, Giachetti A.
    J Pharmacol Exp Ther; 1991 Jun 02; 257(3):1172-8. PubMed ID: 1710662
    [Abstract] [Full Text] [Related]

  • 20. Investigation of neurokinin-2 and -3 receptors in the human and pig bladder.
    Templeman L, Sellers DJ, Chapple CR, Rosario DJ, Hay DP, Chess-Williams R.
    BJU Int; 2003 Nov 02; 92(7):787-92. PubMed ID: 14616468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.